Results 11 to 20 of about 2,415,477 (301)

The Hidden Impact of the COVID-19 Pandemic on Routine Childhood Immunization Coverage in Cameroon

Vaccines, 2023
Background: The third round of the global pulse survey demonstrated that the abrupt and rapid progression of the COVID-19 pandemic significantly disrupted childhood immunization in many countries.
Yauba Saidu, Pietro Di Mattei, Sangwe Clovis Nchinjoh, Nnang Nadege Edwige, Bernard Nsah, Nkwain Jude Muteh, Shalom Tchokfe Ndoula, Rakiya Abdullahi, Chen Stein Zamir, Andreas Ateke Njoh, Amani Adidja, Sidy Ndiaye, Owens Wiwa, Emanuele Montomoli, Sue Ann Costa Clemens   +14 more
doaj   +1 more source

Impact of periodic intensification of routine immunization within an armed conflict setting and COVID-19 outbreak in Cameroon in 2020

Conflict and Health, 2022
Introduction Cameroon’s Southwest Region (SW) has been hit by an armed conflict for over half a decade now, negatively affecting the region’s routine immunization and disease surveillance activities.
Andreas Ateke Njoh, Yauba Saidu, Hassan Ben Bachir, Shalom Tchokfe Ndoula, Eric Mboke, Raoul Nembot, Afizu Chrakoh Tambasho, Messang Blandine Abizou, Judith Seungue, Clarence Mbanga, Victor Njie Mbome   +10 more
doaj   +1 more source

Applying real-world data from expanded-access (“compassionate use”) patients to drug development

Journal of Clinical and Translational Science, 2023
Our drug development process has produced many life-saving medications, but patients experiencing rare diseases and similar conditions often are left with limited options for treatment.
June S. Wasser, David J. Greenblatt
doaj   +1 more source

The faces behind vaccination: unpacking the attitudes, knowledge, and practices of staff of Cameroon’s Expanded program on Immunization

Human Resources for Health, 2023
Background Immunization is regarded as one of the most cost-effective public health interventions in global health. However, its cost-effectiveness depends greatly on the knowledge and skills of vaccinators.
Yauba Saidu, Jessica Gu, Budzi Michael Ngenge, Sangwe Clovis Nchinjoh, Amani Adidja, Nadege Edwidge Nnang, Nkwain Jude Muteh, Vouking Marius Zambou, Clarence Mvalo Mbanga, Valirie Ndip Agbor, Diaby Ousmane, Andreas Ateke Njoh, Junie Flegere, Demba Diack, Owens Wiwa, Emanuele Montomoli, Sue Ann Costa Clemens, Ralf Clemens   +17 more
doaj   +1 more source

Generating Evidence from Expanded Access Use of Rare Disease Medicines: Challenges and Recommendations

Frontiers in Pharmacology, 2022
Patients with rare diseases often have limited or no options for approved treatments or participation in clinical trials. In such cases, expanded access (or “compassionate use”) provides a potential means of accessing unapproved investigational medicines.
Tobias B. Polak, Tobias B. Polak, Tobias B. Polak, Tobias B. Polak, David G. J. Cucchi, David G. J. Cucchi, Joost van Rosmalen, Joost van Rosmalen, Carin A. Uyl-de Groot, Jonathan J. Darrow, Jonathan J. Darrow   +10 more
doaj   +1 more source

Assessment of immunization data management practices in Cameroon: unveiling potential barriers to immunization data quality

BMC Health Services Research, 2023
Background One crucial obstacle to attaining universal immunization coverage in Sub-Saharan Africa is the paucity of timely and high-quality data. This challenge, in part, stems from the fact that many frontline immunization staff in this part of the ...
Yauba Saidu, Jessica Gu, Budzi Michael Ngenge, Sangwe Clovis Nchinjoh, Amani Adidja, Nadege Edwidge Nnang, Nkwain Jude Muteh, Vouking Marius Zambou, Clarence Mbanga, Valirie Ndip Agbor, Diaby Ousmane, Andreas Ateke Njoh, Junie Flegere, Demba Diack, Owens Wiwa, Emmanuele Montomoli, Sue Ann Costa Clemens, Ralf Clemens   +17 more
doaj   +1 more source

Phage Therapy in the 21st Century: Is There Modern, Clinical Evidence of Phage-Mediated Efficacy?

Pharmaceuticals, 2021
Many bacteriophages are obligate killers of bacteria. That this property could be medically useful was first recognized over one hundred years ago, with 2021 being the 100-year anniversary of the first clinical phage therapy publication. Here we consider
Stephen T. Abedon, Katarzyna M. Danis-Wlodarczyk, Diana R. Alves   +2 more
doaj   +1 more source

The High “Cost” of Experimental Drugs Obtained Through Health Litigation in Brazil

Frontiers in Pharmacology, 2020
BackgroundBrazilian patients have legal right to access unlicensed medicines undergoing clinical research, if there is evidence of efficacy and safety. This study investigated the occurrence of serious adverse events related to very high-cost medicines ...
Ricardo Eccard da Silva, Elisangela da Costa Lima, Maria Rita C. G. Novaes, Maria Rita C. G. Novaes, Claudia G. S. Osorio-de-Castro   +4 more
doaj   +1 more source

A Clean Energy Roadmap: Forging the Path Ahead [PDF]

, 2010
Calls for better-aligned state policies, reduced market uncertainty, expanded power grid access, interagency and cross-sector collaboration, and a robust research-to-commercialization pipeline to boost investment in clean energy innovations and new ...

core   +1 more source

Improving data use for decision making by neglected tropical disease program teams: eight use cases [version 1; peer review: 2 approved, 1 approved with reservations]

Gates Open Research, 2021
Background: The achievement of neglected tropical diseases (NTDs) program goals depends on numerous factors, including the ability of national programs to use high-quality, timely data to inform their decision-making and program delivery.
Lakshmi Balachandran, Liz Grubin, Nana-Kwadwo Biritwum, Sarah Bartlett, Fiona Fleming, Simon Brooker, Sultani Matendechero, Karsor Kollie, Maria Rebollo Polo, TJ Muehleman, Birhan Mengistu, Brooke Partridge, Upendo Mwingira, Modeste Tezembong, Alex Pavluck, Rosalyn Yeary, Derek Treatman, Honorat Zoure, Katie Zoerhoff   +18 more
doaj   +1 more source